UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - microbiome
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Compounds for Improved Psychological and Resilience Measures Associated with Physical Activity (UCLA Case No. 2022-272)
UCLA researchers from the Department of Medicine have identified
microbiome
and metabolic markers associated with high physical activity in an obese population, leading to possible therapies that may provide the positive effects of physical activity. BACKGROUND: It is known that physical activity has a multitude of beneficial effects on health. On...
Published: 11/18/2024
|
Inventor(s):
Arpana Church
Keywords(s):
Bacteria
,
Exercise
,
Gastroenterology & Digestive Disease
,
gut-brain axis
,
Human Gastrointestinal Tract
,
metabolomics
,
microbiome
,
MRI
,
Nutraceuticals / Probiotics
,
obesity
,
physical activity
,
prebiotics
,
Psychology
Category(s):
Therapeutics > Gastroenterology
,
Therapeutics > Psychiatry And Mental Health
,
Therapeutics > Metabolism And Endocrinology
Dissecting Microbiota-Gut-Brain Interactions for the Anti-Seizure Effects of the Ketogenic Diet (UCLA Case No. 2025-006)
UCLA researchers from the Department of Integrative Biology & Physiology have identified specific components of ketogenic diets that alter the
microbiome
and improve seizure resistance, providing valuable data to optimize diet treatments for refractory epilepsy. BACKGROUND: Refractory epilepsy, a disease characterized by uncontrolled seizures,...
Published: 9/19/2024
|
Inventor(s):
Elaine Hsiao
Keywords(s):
diet
,
dietary fiber
,
Epilepsy
,
gut
,
gut-brain axis
,
ketogenic diet
,
microbiome
,
pediatrics
,
seizure
Category(s):
Therapeutics > Gastroenterology
,
Therapeutics > CNS and Neurology
,
Therapeutics > Metabolism And Endocrinology
Nisin-Based Formulations for Oral and Systemic Conditions (UCLA Case Nos. 2023-133 and 2022-306)
UCLA researchers in the Department of Dentistry have found a novel use for nisin alone, and in formulations, for use in the treatment of Alzheimer’s disease, and multiple inflammation states such as brain inflammation, joint inflammation, oral inflammation, systemic inflammation, inflammatory bowel diseases, and non-alcoholic fatty liver disease...
Published: 9/19/2024
|
Inventor(s):
Yvonne Kapila
Keywords(s):
Alzheimers disease
,
Antibacterial
,
gut inflammation
,
Inflammation
,
microbiome
,
nanoparticle delivery system
,
Nanoparticles
,
nisin
,
oral inflammation
,
periodontal disease
,
periodontal inflammation
,
periodontal regeneration
Category(s):
Therapeutics > CNS and Neurology